-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Nr8njypSKTIDo28zEzq+1MrSHBC9ma42uiXD0dXwmuuewMDknCWCMnT347c3G8Pv GgNW4m5EgF1CWvq5sr79xw== 0001062822-09-000127.txt : 20100426 0001062822-09-000127.hdr.sgml : 20100426 20091214162521 ACCESSION NUMBER: 0001062822-09-000127 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20091214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LEXICON PHARMACEUTICALS, INC./DE CENTRAL INDEX KEY: 0001062822 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 760474169 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 8800 TECHNOLOGY FOREST PLACE CITY: THE WOODLANDS STATE: TX ZIP: 77381 BUSINESS PHONE: 2818633000 MAIL ADDRESS: STREET 1: 8800 TECHNOLOGY FOREST PLACE CITY: THE WOODLANDS STATE: TX ZIP: 77381 FORMER COMPANY: FORMER CONFORMED NAME: LEXICON GENETICS INC/TX DATE OF NAME CHANGE: 20000126 CORRESP 1 filename1.htm correspondence.htm
 
[LEXICON PHARMACEUTICALS LETTERHEAD]


December 14, 2009
 


Securities and Exchange Commission
Division of Corporate Finance
100 F Street, N.E.
Washington, D.C. 20549

Attention:                      Ms. Nandini Acharya

Re:           Lexicon Pharmaceuticals, Inc.
Form 10-K for the fiscal year ended December 31, 2008
Filed March 6, 2009
File No. 000-30111

DEF 14A
Filed March 13, 2009
File No. 000-30111

Dear Ms. Acharya:

We are in receipt of the comment letter dated November 30, 2009 from the Securities and Exchange Commission’s staff with respect to the above-referenced filings.  We are currently preparing our responses to those comments and respectfully request an additional 10 business days within which to provide you with those responses.
 
Please contact me at (281) 863-3321 if you are unable to grant this requested extension or if you have any additional comments or questions concerning this letter.
 
Very truly yours,

/s/ Jeffrey L. Wade

Jeffrey L. Wade
Executive Vice President and
General Counsel
 -----END PRIVACY-ENHANCED MESSAGE-----